¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2020 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ : 2020-08-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2020 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ : 2020-08-21
±³À°ÀÏÀÚ : 2020-08-21
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À° (½Ç½Ã°£)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2020 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ(18.7 ¸íĪº¯°æ ´ëÇÑÈ­Çпä¹ýÇÐȸ)
´ã´çÀÚ : ¹Ú½ÂÀ±
¿¬¶ôó : 02-557-1755  
À̸ÞÀÏ : ksc@ksac.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í È¸¿ø Àü¹®ÀÇ 10¸¸¿ø, ÀüÀÓÀÇ 8¸¸¿ø, Àü°øÀÇ 5¸¸¿ø ºñȸ¿ø Àü¹®ÀÇ 12¸¸¿ø, ÀüÀÓÀÇ 10¸¸¿ø, Àü°øÀÇ 7¸¸¿ø ÀÏ¹Ý 12¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 08:50~09:30 BIKTARVY with Korean patients: a strategy to improve patients¡¯ adherence  Áø¹ü½Ä(±¹¸³Áß¾ÓÀÇ·á¿ø) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 09:30~10:05 Epidemiology of COVID-19 in Korea  Ãµº´Ã¶(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 10:05~10:40 Infection prevention and control in community and hospitals in Korea  ÀÌÀç°©(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 10:40~11:15 Laboratory response to COVID-19 pandemic and future perspectives  ÀÌÇõ¹Î(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 11:15~11:55 Clinical features and management of COVID-19 in adult patients  ±è³²Áß(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 11:55~12:30 Clinical features and management of COVID-19 in pediatric patients  ÃÖÀºÈ­(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 12:30~13:10 Therapeutic role of ¥â-lactam/¥â-lactamase inhibitors to gram-negative nosocomial pneumonia, with special emphasis on ceftolozane/tazobactam  °­Ã¶ÀÎ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 13:10~13:50 New consideration for PLHIV ; metabolic syndrome & Long term toxicity  ±è¿¬¼÷(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 14:00~14:30 Recent ethical topics in biomedical articles  È«¼ºÅÂ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 16:00~16:30 Pediatric use of fluoroquinolone and doxycycline  ¹Ú¼öÀº(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 16:30~17:00 IV vs. oral therapy for severe infectious diseases  ¹Ú±âÈ£(°æÈñÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 17:00~17:40 Carbapenem-sparing therapy in the era of multidrug resistance  °­Ã¶ÀÎ(¼º±Õ°üÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2020 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ : 2020-08-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÁ¾¾ç³»°úÇÐȸ (¿Â¶óÀÎ) Best of ASCO 2020 in Korea : 2020-08-21
´ÙÀ½±Û (¿Â¶óÀÎ) 2020³â ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ : 2020-08-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21075 ¼­¿ï 2024³â ´ëÇѼö¸é¿¬±¸ÇÐȸ Á¤±â Çмú´ëȸ DAY 1 : 2024-07-06 0 5 2024-06-18
21074 ±¤ÁÖ 2024³âµµ ´ëÇÑÇǺΰúÀÇ»çȸ ±¤ÀüÁöºÎ ±³À°½ÉÆ÷Áö¿ò : 2024-07-06 0 4 2024-06-18
21073 ¼­¿ï (¿Â¶óÀÎ) 2024³â ÇϹݱâ ÀÇÇй°¸® Àü¹®±³À° 2 : 2024-07-06 0 2 2024-06-18
21072 ´ë±¸ 2024 ´ëÇѺñ¸¸ÇÐȸ Obesity Summer Çмú´ëȸ : 2024-07-06 0 6 2024-06-18
21071 ¼­¿ï 2024 ´ëÇѽÉÀåÇÐȸ ½ÉÀåÁ¾¾çÇבּ¸È¸ ÇÏ°è ½ÉÆ÷Áö¿ò : 2024-07-06 0 4 2024-06-18
21070 ¼­¿ï ´ëÇѺҾÈÀÇÇÐȸ (¿Â¶óÀÎ) ½ºÆ®·¹½º°ü¸® ÇÁ·Î±×·¥ : 2024-07-06 0 4 2024-06-18
21069 ¼­¿ï 2024³â Á¦25ȸ ´ëÇÑÇǺΰúÇÐȸ ¿¬¼ö±³À° : Conerstone and General : 2024-07-06 0 2 2024-06-18
21068 ´ëÀü 2024 ´ëÀü¼­±¸ÀÇ»çȸ Çмú´ëȸ : 2024-07-05 0 4 2024-06-18
21067 °æºÏ ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ë±¸°æºÏÁöȸ - Á¦3ȸ ¿¬¼ö°­Á : 2024-07-05 0 5 2024-06-18
21066 ´ë±¸ °è¸í´ëÇб³ µ¿»êÀÇ·á¿ø 125Áֳ⠱â³ä ±¹Á¦Çмú´ëȸ : 2024-07-05 0 1 2024-06-18
21065 ¼­¿ï ´ëÇÑÅ»ÀåÇÐȸ 18th Congress of the KHS & 2024 International Symposium(1ÀÏÂ÷) : 2024-07-05 0 2 2024-06-18
21064 ¼­¿ï Çѱ¹ÀÇÇй°¸®ÇÐȸ (¿Â¶óÀÎ) 2024³â ÇϹݱâ ÀÇÇй°¸® Àü¹®±³À° 1 : 2024-07-05 0 1 2024-06-18
21063 °æ³² ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦111Â÷ ¿¬¼ö±³À° : 2024-07-04 0 2 2024-06-18
21062 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(4ÀÏÂ÷) : 2024-07-04 0 0 2024-06-18
21061 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ÀçÅÃÀÇ·á ȯÀÚ Áø·áÀÇ ½ÇÁ¦ : 2024-07-04 0 1 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷